Ara
Toplam kayıt 31, listelenen: 21-30
Is fibrinolytic therapy really safe in the treatment of prosthetic valve thrombosis in patients with high INR?
(Wiley, 2021)
To the Editor,
We have recently read with great interest the article by Farzaneh et al.1 entitled “Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ...
Low Dose and Slow/Ultra-Slow Infusion Thrombolytic Therapy Regimens are Effective and Safe in Patients With Prosthetic Valve Thrombosis
(Elsevier Science Inc, 2020)
To the Editor,We have recently read with great interest the article by Milneet al. entitled‘Management and outcomes of prosthetic valvethrombosis. An Australian case series from the NorthernTerritory’[1].
The relationship between incomplete surgical obliteration of the left atrial appendage and thromboembolic events after mitral valve surgery (from the ISOLATE Registry)
(Springer, 2021)
Left atrial appendage (LAA) is a common site of thrombus formation especially in patients with atrial fibrillation (AF). Complete surgical LAA closure (cSLC) is the surgical aim, however incomplete surgical LAA closure ...
The Relationship Between HbA1c Level and Beck Depression Scale in Patients with Heart Failure with Type 2 Diabetes Mellitus
(2018)
Introduction: Multiple studies have shown the relationship between heart failure (HF) and development of depression. Several studies have demonstrated worse perception of quality of life among patients with type 2 diabetes ...
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism
(Lippincott Williams & Wilkins, 2020)
The patients with intermediate-high risk pulmonary embolism who have acute right ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise may be candidates for thrombolytic therapy. Alternative ...
The value of brain natriuretic peptide in the prosthetic valve thrombosis
(Lippincott Williams & Wilkins, 2020)
We aimed to investigate how prosthetic valve thrombosis (PVT) affects brain natriuretic peptide (BNP) levels and how BNP changes following thrombolytic therapy. The study included 70 consecutive patients with left-sided ...
Normal reference values for mechanical mitral prosthetic valve inner diameters and areas assessed by two-dimensional and real-time three-dimensional transesophageal echocardiography
(Springer, 2021)
It was previously observed that two dimensional (2D) Doppler derived and real-time three-dimensional (RT-3D) directly measured valve areas were smaller than reported manufacturer sizes. It may be helpful to obtain the ...
A comprehensive review of the diagnosis and management of mitral paravalvular leakage
(Turkish Soc Cardiology, 2020)
Mitral paravalvular leaks (PVLs) commonly occur in patients with prosthetic valves. Paravalvular defects may be clinically inconsequential and may aggravate hemolysis or cause heart failure through regurgitation. Accordingly, ...
Evaluation of the relationship between platelet indices and spontaneous echo contrast in patients with mitral prosthetic heart valves
(2020)
Objective: Spontaneous echo contrast (SEC) is defined as dynamic, smoke-like echoes within the cardiac cavities with a characteristic swirling motion seen on echocardiography. Clinical studies have demonstrated that SEC ...
Improvement of endothelial function early after thrombolytic therapy in patients with prosthetic heart valve thrombosis
(2020)
Objective: Prosthetic valve thrombosis (PVT) is a serious complication among patients with prosthetic heart valves. Thrombolytic therapy (TT) is now widely used as first-line treatment for PVT. Endothelial dysfunction has ...